Interstitial Lung Disease Trial, Recruiting NCT07339644 Sponsor: The Second Affiliated Hospital of Chongqing Medical University Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT07339644
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 85 years old (inclusive), of any sex
  • You have been diagnosed with a lung cancer or a cancer that has spread to the lungs, and your doctors have recommended radiation treatment to the chest area
  • You are scheduled to receive a specific type of chest radiation therapy (either a standard course or a more focused, shorter course called SBRT), and you are able to complete a special pre-treatment breathing scan called a 4DCT
  • Your general health and organ function are at a level your doctors consider suitable for radiation treatment, and you are able to carry out everyday activities with little or no limitation (confirm with trial site)
  • You do not have any reason that would completely prevent lung function breathing tests; people with moderate long-term lung disease may still be considered if their doctors feel radiation treatment is safe for them
  • You are able to attend all treatment sessions and follow-up appointments as required
  • You are willing and able to give written consent to take part

Who may not be able to join:

  • You are pregnant or breastfeeding, or pregnancy has not been ruled out before starting radiation treatment
  • You are younger than 18 or older than 85 years of age
  • You have a serious, uncontrolled heart or lung condition, or another severe health problem that makes radiation treatment too risky (for example, severe heart failure, an unstable heart or lung condition, or a serious active lung infection)
  • You have previously received a high dose of radiation to the same area of the chest, making it unsafe to treat that area again
  • You have another active or advanced cancer that needs to be treated as a priority and could affect the results of this study
  • You have recently taken part in another clinical trial involving a treatment, or you are currently receiving another experimental treatment that could interfere with this study
  • You have a severe mental health, memory, or other condition that would prevent you from cooperating with the radiation treatment or attending follow-up visits
  • The special breathing scan (4DCT) either produced poor-quality images or could not be used to create the required treatment plan
  • Your doctors have identified any other reason they feel it would not be safe or appropriate for you to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: zhengjun Guo, MD., The Second Clinical College of Chongqing Medical University: The Second Affiliated Hospital of Chongqing Medical University

Phone: +86 18982928222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Registry
ClinicalTrials.gov
Start date
24 October 2025
Est. completion
24 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of Radiation-Induced Lung Injury (Grade ≥2)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov